ABA Fundamentals

Drug effects on repeated acquisition: comparison of cumulative and non-cumulative dosing.

Thompson et al. (1983) · Journal of the experimental analysis of behavior 1983
★ The Verdict

Cumulative dosing saves time but can make drug effects look bigger or smaller depending on the drug.

✓ Read this if BCBAs who read pre-clinical drug papers to pick treatments or to design animal models.
✗ Skip if Clinicians who only run pure behavioral plans with no medication component.

01Research in Context

01

What this study did

The team gave three drugs to lab animals using two dosing styles. One style added each dose on top of the last. The other gave each dose on separate days.

They watched how the animals learned a new chain of button presses after every drug shot.

02

What they found

Phencyclidine and pentobarbital looked stronger when each dose was given alone. D-amphetamine looked stronger when doses were piled up.

Cumulative dosing changed the size of the drug effect, not just the speed of the test.

03

How this fits with other research

Webb et al. (1999) ran a similar comparison in humans with triazolam. They also saw curve shifts, yet still liked the time-saving one-day method. The animal and human data line up: cumulative dosing works, but the numbers move.

Wilkie et al. (1981) used the same repeated-acquisition task to show naloxone blocks morphine errors. That paper proves the task is sensitive to drug interactions, so the dosing-style differences seen here are likely real.

McMillan (1979) and Hearst (1960) both found that d-amphetamine cuts response rate under fixed schedules. The current study shows the same drug also hurts new learning, and the size of that hurt depends on how you give the doses.

04

Why it matters

If you ever compare drug effects across studies, check how the doses were given. A "strong" result might look weak simply because the earlier doses were still in the body. When you read pre-clinical charts, note whether the curve came from one long session or many short ones.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Before you trust any dose-effect curve, scroll the method section and write "cumulative" or "separate" at the top of the page.

02At a glance

Intervention
not applicable
Design
single case other
Population
not specified
Finding
negative

03Original abstract

Pigeons acquired a different four-response chain each session by responding sequentially on three keys in the presence of a sequence of four colors. The response chain was maintained by food presentation under a fixed-ratio schedule. Errors produced a brief timeout but did not reset the chain. Each day there were four 15-minute sessions, with a 10-minute inter-session interval. Cumulative dose-effect curves for phencyclidine, pentobarbital, and d-amphetamine were obtained by giving an injection before each of the four sessions; successive injections increased the cumulative dose in equally spaced logarithmic steps. For comparison, non-cumulative doses of each drug (i.e., doses not preceded by other doses on the same day) were also tested. As the cumulative dose of each drug increased, the overall response rate decreased, the percent errors increased, and there was less within-session error reduction (acquisition). With phencyclidine and pentobarbital, the rate-decreasing and error-increasing effects tended to be greater with a non-cumulative dose than with the corresponding cumulative dose. In contrast, with d-amphetamine, the effects were considerably greater with the cumulative doses. The results indicate that although the cumulative-dosing procedure saved a substantial amount of time in determining dose-effect curves, there were quantitative differences in effects between cumulative and non-cumulative doses.

Journal of the experimental analysis of behavior, 1983 · doi:10.1901/jeab.1983.39-175